FMT for Crohn's disease (FEMTRAC) study

Multicenter randomized controlled trial to study the efficacy of multidonor fecal microbiota transplantation for Crohn's disease

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs041190022

Enrollment

Registered

2019-04-22

Start date

2018-10-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease

Interventions

fecal microbiota transplantation

D000069467

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with active Crohn's disease (CDAI 150 or more)

Exclusion criteria

Exclusion criteria: 1.past history of allergy to drugs used in this study 2.possible of documented pregnant women 3.patients with fistula, penetration, and perforation except anal fistula

Design outcomes

Primary

Measure	Time frame
Improvement of CDAI score	—

Secondary

Measure	Time frame
1. IBDQ 2. modified SESCD 3. hydrogen and methane level in glucose breath test 4. urine lactulose mannnitol ratio 5. change in fecal microbiome and metabolome	—

Contacts

Public ContactNaoki Ohmiya

Fujita Health University Hospital

nohmiya@fujita-hu.ac.jp+81-562-93-9240

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026